EPIS_B: Operating losses narrowed as sales grew and real estate investments began, but financing risks remain

About this update from Episurf Medical Ab Class B

Net sales grew modestly to SEK 13.5m in 2025, with operating losses narrowing to SEK -57.9m. The company diversified into real estate, executed leadership changes, and raised capital through rights issues, but faces material uncertainty regarding future financing and going concern.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Episurf Medical Ab Class B